Telix Pharmaceuticals (Innovations) Pty Limited clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: IPAX BrIGHT · TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone · Recurrent Glioblastoma Primary completion pushed from Jul 2027 to Jul 2028
- Minor: BiPASS · PSMA PET Combined With MRI for the Detection of PCa Enrollment closed, study ongoing
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-12 | NCT07931261 [18F]FET PET for Differentiating Tumor Progression vs Treatment-Related Changes in Brain… | Phase 3 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 3 | |
| Phase 2 | 1 | |
| Phase 3 | 6 |
Disease areas by active trials
Kidney Cancer (4) · Glioblastoma (2) · Glioma (2) · Prostate Cancer (2)
Get alerts when Telix Pharmaceuticals (Innovations) Pty Limited's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.